Procedure- and device-related complications of Intrathecal baclofen administration for management of adult muscle hypertonia: A review

Neurorehabilitation and Neural Repair

Volumn 24, Issue 7, 2010, Pages 609-619

  Stetkarova, Ivana ^a,b   Yablon, Stuart A ^b,c   Kofler, Markus ^d   Stokic, Dobrivoje S ^b  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b METHODIST REHABILITATION CENTER   (United States)

^c BAYLOR HEALTH CARE SYSTEM   (United States)

^d Hochzirl Hospital   (Austria)

Author keywords

brain injury; intrathecal baclofen; spasticity; spinal cord injury rehabilitation

Indexed keywords

BACLOFEN;

ABDOMINAL INJURY; BACTERIAL MENINGITIS; CATHETER COMPLICATION; DECUBITUS; DEVICE INFECTION; DRUG IMPLANT; FIBROSIS; FOLLOW UP; HEADACHE; HEMATOMA; HUMAN; IATROGENIC DISEASE; INFUSION; LEG PAIN; LIQUORRHEA; LYMPHOCELE; MEDLINE; MENINGITIS; MENINGOCELE; MUSCLE HYPERTONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PSEUDOTUMOR; REVIEW; SEROMA; SKIN NECROSIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THORAX PAIN; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; BACLOFEN; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MUSCLE HYPERTONIA; POSTOPERATIVE COMPLICATIONS;

EID: 77956377628     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968310363585     Document Type: Review

References (57)

1. Albright AL, Ferson SS Intrathecal baclofen therapy in children. Neurosurg Focus. 2006 ; 21: e3.
2. Ivanhoe CB, Tilton AH, Francisco GE Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabil Clin N Am 2001 ; 12: 923-938.
3. Guillaume D., Van Havenbergh A., Vloeberghs M., Vidal J., Roeste G. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil. 2005 ; 86: 2165-2171.
4. Vender JR, Hughes M., Hughes BD, Hester S., Holsenback S., Rosson B. Intrathecal baclofen therapy and multiple sclerosis: outcomes and patient satisfaction. Neurosurg Focus. 2006 ; 21: e6.
5. Bensmail D., Quera Salva MA, Roche N., et al. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. Neurology. 2006 ; 67: 1432-1436.
6. Bensmail D., Ward AB, Wissel J., et al. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity. Neurorehabil Neural Repair. 2009 ; 23: 546-552.
7. Ivanhoe CB, Francisco GE, McGuire JR, Subramanian T., Grissom SP Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil. 2006 ; 87: 1509-1515.
8. Kolaski K., Logan LR A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation. 2007 ; 22: 383-395.
9. Turner JA, Sears JM, Loeser JD Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin J Pain. 2007 ; 23: 180-195.
10. Ruan X. Drug-related side effects of long-term intrathecal morphine therapy. Pain Physician. 2007 ; 10: 357-366.
11. Francisco GE, Saulino MF, Yablon SA, Turner M. Intrathecal baclofen therapy: an update. PM R. 2009 ; 1: 852-858.
12. Ordia JI, Fisher E., Adamski E., Chagnon KG, Spatz EL Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation. 2002 ; 5: 16-24.
13. Heetla HW, Staal MJ, Kliphuis C., van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord. 2009 ; 47: 751-756.
14. Penn RD, York MM, Paice JA Catheter systems for intrathecal drug delivery. J Neurosurg. 1995 ; 83: 215-217.
15. Nielsen JF, Hansen HJ, Sunde N., Christensen JJ Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin Neurol Neurosurg. 2002 ; 104: 142-145.
16. Coffey JR, Cahill D., Steers W., et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993 ; 78: 226-232.
17. Vidal J., Fenollosa P., Martin E., et al. Safety and efficacy of intrathecal baclofen infusion by implantable pump for the treatment of severe spinal spasticity: a Spanish multicenter study. Neuromodulation. 2000 ; 3: 175-182.
18. Penn RD Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992 ; 77: 236-240.
19. Ordia JI, Fischer E., Adamski E., Spatz EL Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg. 1996 ; 85: 452-457.
20. Teddy P., Jamous A., Gardner B., Wang D., Silver J. Complications of intrathecal baclofen delivery. Br J Neurosurg. 1992 ; 6: 115-118.
21. McCall TD, MacDonald JD Cervical catheter tip placement for intrathecal baclofen administration. Neurosurgery. 2006 ; 59: 634-640.
22. Gardner B., Jamous A., Teddy P., et al. Intrathecal baclofen: a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems. Paraplegia. 1995 ; 33: 551-554.
23. Plassat R., Perrouin VB, Menei P., Menegalli D., Mathe JF, Richard I. Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord. 2004 ; 42: 686-693.
24. Ochs G., Struppler A., Meyerson BA, et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry. 1989 ; 52: 933-939.
25. Zahavi A., Geertzen JH, Middel B., Staal M., Rietman JS Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry. 2004 ; 75: 1553-1557.
26. Abel NA, Smith RA Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil. 1994 ; 75: 54-58.
27. Azouvi P., Mane M., Thiebaut JB, Denys P., Remy-Neris O., Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil. 1996 ; 77: 35-39.
28. Ethans KD, Schryvers OI, Nance PW, Casey AR Intrathecal drug therapy using the Codman Model 3000 Constant Flow Implantable Infusion Pumps: experience with 17 cases. Spinal Cord. 2005 ; 43: 214-218.
29. Meythaler JM, Guin-Renfroe S., Grabb P., Hadley MN Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil. 1999 ; 80: 13-19.
30. Meythaler JM, Guin-Renfroe S., Brunner RC, Hadley MN Intrathecal baclofen for spastic hypertonia from stroke. Stroke. 2001 ; 32: 2099-2109.
31. Dario A., Di Stefano MG, Grossi A., Casagrande F., Bono G. Long-term intrathecal baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand. 2002 ; 105: 83-87.
32. Francisco GE, Hu MM, Boake C., Ivanhoe CB Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj. 2005 ; 19: 359-364.
33. Meythaler JM, McCary A., Hadley MN Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report. J Neurosurg. 1997 ; 87: 415-419.
34. Saltuari L., Kronenberg M., Marosi MJ, et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol (Napoli). 1992 ; 14: 187-194.
35. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS Continuous intrathecal baclofen in spinal cord spasticity: a prospective study. Am J Phys Med Rehabil. 1992 ; 71: 321-327.
36. Saltuari L., Kronenberg M., Marosi MJ, et al. Long-term intrathecal baclofen treatment in supraspinal spasticity. Acta Neurol (Napoli). 1992 ; 14: 195-207.
37. Rifici C., Kofler M., Kronenberg M., Kofler A., Bramanti P., Saltuari L. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol. 1994 ; 9: 29-34.
38. Stayer C., Tronnier V., Dressnandt J., et al. Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology. 1997 ; 49: 1591-1597.
39. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia. 1991 ; 29: 48-64.
40. Francois B., Vacher P., Roustan J., et al. Intrathecal baclofen after traumatic brain injury: early treatment using a new technique to prevent spasticity. J Trauma. 2001 ; 50: 158-161.
41. Schurch B. Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems: case report. Paraplegia. 1993 ; 31: 611-615.
42. Reeves RK, Stolp-Smith KA, Christopherson MW Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phys Med Rehabil. 1998 ; 79: 353-356.
43. Al Khodairy AT, Vuagnat H., Uebelhart D. Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure: a case report. Am J Phys Med Rehabil. 1999 ; 78: 272-277.
44. Bardutzky J., Tronnier V., Schwab S., Meinck HM Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage. Neurology. 2003 ; 60: 1976-1978.
45. Pasquier Y., Cahana A., Schnider A. Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord. 2003 ; 41: 700-702.
46. Boviatsis EJ, Kouyialis AT, Boutsikakis I., Korfias S., Sakas DE Infected CNS infusion pumps: is there a chance for treatment without removal ? Acta Neurochir (Wien). 2004 ; 146: 463-467.
47. Atiyeh BS, Hayek SN, Skaf GS, Al Araj A., Chamoun RB Baclofen pump pocket infection: a case report of successful salvage with muscle flap. Int Wound J. 2006 ; 3: 23-28.
48. Deer TR, Raso LJ, Garten TG Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication. Pain Med. 2007 ; 8: 259-262.
49. Murphy PM, Skouvaklis DE, Amadeo RJ, Haberman C., Brazier DH, Cousins MJ Intrathecal catheter granuloma associated with isolated baclofen infusion. Anesth Analg. 2006 ; 102: 848-852.
50. Martens FM, Somford DM, van Kuppevelt DH, van den Burg MJ, Heesakkers JP Retraction of an intrathecal baclofen infusion catheter following suprapubic cystotomy: a case report. J Rehabil Med. 2009 ; 41: 90-91.
51. Stempien L., Tsai T. Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil. 2000 ; 79: 536-541.
52. Albright AL, Turner M., Pattisapu JV Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg. 2006 ; 104: 233-239.
53. Follett KA, Burchiel K., Deer T., et al. Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation. 2003 ; 6: 32-41.
54. Le Breton F., Daviet JC, Monteil J., et al. Radioisotopic control for baclofen pump catheter failure. Spinal Cord. 2001 ; 39: 283-285.
55. Stokic DS, Yablon SA, Hayes A. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Arch Phys Med Rehabil. 2005 ; 86: 1801-1806.
56. Stokic DS, Yablon SA Neurophysiological basis and clinical applications of the H-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity. Acta Neurochir Suppl. 2007 ; 97: 231-241.
57. Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002 ; 83: 735-741.